• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Arrowhead Research Corp. (ARWR)

    -NasdaqGS
    6.84 Down 0.11(1.58%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:6.95
    Open:6.98
    Bid:6.15 x 5000
    Ask:7.10 x 3300
    1y Target Est:8.88
    Beta:2.48
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:6.80 - 7.12
    52wk Range:4.95 - 17.42
    Volume:657,750
    Avg Vol (3m):1,389,770
    Market Cap:406.97M
    P/E (ttm):N/A
    EPS (ttm):-1.58
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARWR

    Comparison

    Symbol% ChgMkt Cap
    ARWRDown 1.58%406.97M
    PENCDown 16.67%16.12M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,369.25
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :-1.64
    Quarterly EPS Est (Jun-15) :-0.38
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):-0.60

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The company’s principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback